In a recent study, Kalhor and colleagues assessed the three-dimensional structure of human Wnt2-Fzd7 CRD complex via bioinformatics approaches, and the data demonstrated a unique dynamic behavior of Wnt2 upon binding to Fzd7, which is highly useful in targeted therapy for Wnt2-related cancers (86). The gene discussed is FZD7; the disease is cancer.